These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 11755609)

  • 1. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
    Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study.
    Walldius G; Aastveit AH; Jungner I
    J Intern Med; 2006 Mar; 259(3):259-66. PubMed ID: 16476103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).
    Holme I; Aastveit AH; Jungner I; Walldius G
    J Intern Med; 2008 Jul; 264(1):30-8. PubMed ID: 18298486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
    Meisinger C; Loewel H; Mraz W; Koenig W
    Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B/apolipoprotein A-I ratio and apolipoprotein B: long-term predictors of myocardial infarction in initially healthy middle-aged men--a 13-year follow-up.
    Schmidt C; Bergström G
    Angiology; 2014 Nov; 65(10):901-5. PubMed ID: 24277914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
    Dirisamer A; Stadler A; Bucek RA; Widhalm K
    Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of lipids and apolipoproteins in three cultures.
    Solhpour A; Parkhideh S; Sarrafzadegan N; Asgary S; Williams K; Jungner I; Aastveit A; Walldius G; Sniderman A
    Atherosclerosis; 2009 Nov; 207(1):200-7. PubMed ID: 19766218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apolipoproteins are new and better risk indicators of myocardial infarction].
    Walldius G; Jungner I
    Lakartidningen; 2004 Mar; 101(13):1188-94. PubMed ID: 15101244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
    Walldius G; Jungner I
    J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.
    Parish S; Peto R; Palmer A; Clarke R; Lewington S; Offer A; Whitlock G; Clark S; Youngman L; Sleight P; Collins R;
    Eur Heart J; 2009 Sep; 30(17):2137-46. PubMed ID: 19520708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
    Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
    Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
    Oksala N; Seppälä I; Hernesniemi J; Lyytikäinen LP; Kähönen M; Mäkelä KM; Reunanen A; Jula A; Ala-Korpela M; Lehtimäki T
    Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.
    Sniderman AD; Holme I; Aastveit A; Furberg C; Walldius G; Jungner I
    Am J Cardiol; 2007 Jul; 100(2):217-21. PubMed ID: 17631073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study.
    Leiviskä J; Sundvall J; Alfthan G; Jauhiainen M; Salomaa V
    Clin Chim Acta; 2011 May; 412(11-12):1146-50. PubMed ID: 21419755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.